1Ito Y,Takeda T, Wakasa K,et al.Expression of p57/kip2 prorein in pancreatic adenoearcinoma. Pancreas 2001 ; 23 ( 3 ) :246.
2Kamijo T, Bodner S, van de Kamp E, et al. Tumor spectrum in ARE-deficient mice. Cancer Res 1999;59(9) :2217.
3Eymin B, Gazzeri S, Brambilla C,et al. Mare2 overexpreasion and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors.Oncogene 2002;21(17):2750.
4Iida S,Akiyma Y, Nakajima T, et al.Alteration and hypermethylation of the pl4(ARF) gene in gastric caneer.Int J Cromer 2000;87(5) :654.
5Burri N, Shaw P, Bouzourene H, et al. Methylalian silencing and mutation of the p14ARF and p16INK4a genes in colon cancer.Lab Invest 2001;81(20):217.
6Esteller M, Covdon-cardo C, Corn PG, et al. p14^ARF Silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Caneer.Res 2001 ; 16(7) : 2816.
7Korshumov A, Golanov A. Iummunohistochemical analysis of p18INK4C and p14ARF protein expression in 117 oligodendrogliomaz:eorrelation with tumor grade and clinical outcome.Arch Pathol Lab Med 2002;126(1):42.
8Matsuoka S, Edwards MC, Bai C, et al. p57^KIP2, a structurally distinct member of the P21^cipl CDK inhibitor family, is a candidate tumor suppressor gene.Gene Dev 1995;9(6) :650.
9Reid LH, Crider-miller SJ, West A, et al. Genomic organization of the human P57^KIP2 gene and its analysis in the G401 wilms tumor essay.Cancer Res 1996;56:1214.
10Tokino T, Vrano T, Faruhata T,et al. Characterization of the human P57^KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis:Hum Genet 1996;97(5):625.
4Matsuoka S, Edwards MC, Bai C, et al. P57kz, A structurally distinct member of the P21tip1 cdk inhibitor family, Is a candidate tumor suppressor gene [ J ]. Gene Dev, 1995 ;9(6) :650.
5Hall JG. Genomic imprinting:rewie and relevance to human diseases[ J]. Am J Hum genet,1990;46(5) :857.
6Matsuoka S, Thompson J, Edwards M, et al. Imprinting of the gene encoding a human cyclin- dependent kinase inhibitor p57 ki on chromosome 11 pl 5 [ J ]. Proc Nall AcadSci USA, 1996 ;93 (7) :3026-3030.
7Kondo M, Matsuoka S, Vchida K, et al. Selective maternal- alleleloss in human lung cancers of the maternally expressed P57ki gene at 11 pl505Oncogene, 1996; 12 : 1365.
8Gaston V, Le bouc Y, Soupre V, et al. Assessmeng of P57ki gene mutation in beckwith-wiedemann syndrome [ J ]. Horm Res,2000;54 ( 1 ) : 1-5.
9Lee MH, Reynisdottir I, Massague J, et al. Cloning of p57 kip2, A cyclin- dependen kinase inhibitor with unique domain structure and tissue distribution [ J ]. Genes Dev,1995 ;9(6) :639-649.
10Watanabe H, Pan ZQ, Schreiber - agus N, et al. Suppression of cell transformation by the cyclin- dependent kinase inhibitor p57 kip 2 requires binding to proliferating cell nuclear antigen[ J]. Proc Natl Acad Sci US A, 1998 ;95 (4) : 1392-1397.
